SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SWOG | S1007-Breast,Adj,N1,Endocrine+/-Chemo | 1 | N | 1 Recurrence Score testing | 9400 | 148 | 0 | 0 | 0 | 0 | 0 | 02/28/2011 | 421 | 180 |
148 | 0 | 0 | 0 | 0 | 0 | |||||||||
2 | N | 2 Chemo and Endocrine Therapy | 5000 | 48 | 0 | 0 | 0 | 0 | 0 | 02/28/2011 | ||||
3 Endocrine Therapy Alone | 59 | 0 | 0 | 0 | 0 | 0 | ||||||||
107 | 0 | 0 | 0 | 0 | 0 | |||||||||
SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SWOG | S1007-Breast,Adj,N1,Endocrine+/-Chemo | 1 | N | 1 Recurrence Score testing | 9400 | 132 | 0 | 0 | 0 | 0 | 0 | 02/28/2011 | 421 | 180 |
132 | 0 | 0 | 0 | 0 | 0 | |||||||||
2 | N | 2 Chemo and Endocrine Therapy | 5000 | 44 | 0 | 0 | 0 | 0 | 0 | 02/28/2011 | ||||
3 Endocrine Therapy Alone | 52 | 0 | 0 | 0 | 0 | 0 | ||||||||
96 | 0 | 0 | 0 | 0 | 0 | |||||||||
SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SWOG | S1007-Breast,Adj,N1,Endocrine+/-Chemo | 1 | N | 1 Recurrence Score testing | 9400 | 16 | 0 | 0 | 0 | 0 | 0 | 02/28/2011 | 421 | 180 |
16 | 0 | 0 | 0 | 0 | 0 | |||||||||
2 | N | 2 Chemo and Endocrine Therapy | 5000 | 4 | 0 | 0 | 0 | 0 | 0 | 02/28/2011 | ||||
3 Endocrine Therapy Alone | 7 | 0 | 0 | 0 | 0 | 0 | ||||||||
11 | 0 | 0 | 0 | 0 | 0 | |||||||||